SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 571 filers reported holding SEAGEN INC in Q1 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,035,729 | +32.6% | 19,023 | +20.3% | 0.22% | +36.8% |
| Q2 2023 | $3,043,562 | +0.8% | 15,814 | +6.0% | 0.16% | -12.8% |
| Q1 2023 | $3,019,638 | +0.4% | 14,914 | -36.3% | 0.19% | -4.1% |
| Q4 2022 | $3,008,805 | -6.0% | 23,413 | +0.1% | 0.20% | -15.2% |
| Q3 2022 | $3,200,000 | -26.0% | 23,388 | -4.3% | 0.23% | -16.4% |
| Q2 2022 | $4,325,000 | +8.0% | 24,446 | -12.0% | 0.28% | +63.7% |
| Q1 2022 | $4,003,000 | -23.4% | 27,790 | -17.8% | 0.17% | -1.8% |
| Q4 2021 | $5,225,000 | -18.3% | 33,800 | -10.3% | 0.17% | -20.8% |
| Q3 2021 | $6,398,000 | +11.5% | 37,680 | +3.6% | 0.22% | +11.9% |
| Q2 2021 | $5,739,000 | +10.4% | 36,355 | -2.9% | 0.19% | -3.5% |
| Q1 2021 | $5,198,000 | -19.2% | 37,431 | +2.0% | 0.20% | -28.8% |
| Q4 2020 | $6,430,000 | – | 36,715 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |